|
|
| | Tanomastat Basic information |
| | Tanomastat Chemical Properties |
| Melting point | 110-110.5°C | | Boiling point | 620.1±55.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,2-8°C | | solubility | Acetone (Slightly), Chloroform (Slightly), Ethyl Acetate (Slightly) | | form | Solid | | pka | 4.01±0.23(Predicted) | | color | White to Off-White | | CAS DataBase Reference | 179545-77-8 |
| | Tanomastat Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | A Matrix Metalloproteinase inhibitor. An angiogenesis inhibitor.
Optical Rotation +82?(C 1.5 acetone) | | Uses | A Matrix Metalloproteinase inhibitor. An angiogenesis inhibitor.Optical Rotation +82° (C 1.5 acetone). | | Uses | Tanomastat is an orally available, non-peptidic inhibitor of matrix metalloproteinase-2 (MMP-2), MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively). It is active in various animal models of tumor metastasis and has been used in a phase III clinical trial in pancreatic, SCLC, NSCLC, and ovarian cancer patients. | | Definition | ChEBI: Tanomastat is an organochlorine compound and a member of biphenyls. |
| | Tanomastat Preparation Products And Raw materials |
|